FDA lifts clinical hold following review of Company’s Complete Response submission.Company expects to restart U.S. enrollment in late 2025 or early 2026 across 20 clinical sites.Early data suggests that LTI-03 may not only slow fibrosis but also promote lung healing. AUSTIN, Texas, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fi ...

公司战略与定位 - 公司宣布大幅扩展其比特币挖矿业务，总挖矿算力达到约11.3 EH/s，使其成为全球顶级的公开上市比特币矿商之一 [1][2] - 此次扩张是公司数字基础设施战略的一部分，旨在为下一代游戏和娱乐平台构建能力，将数字货币、人工智能、用户参与度和计算能力与传统游戏体验相融合 [1][3][5] - 公司定位为游戏娱乐公司中率先建立大规模加密和高性能计算基础设施的先锋 [1][5] 运营与财务影响 - 新增挖矿算力约8.19 EH/s，通过收购获得，交易对价为发行最多314,515,762股A类普通股，预计在2025年12月15日前完成 [4] - 运营预计每月产生约160枚比特币，将为公司创造显著的新收入来源，并强化其财务基础 [2] - 此次扩张与公司长期愿景及近期宣布的阿布扎比投资办公室合作伙伴关系相符，支持其在阿布扎比设立部门总部 [3] 管理层评论摘要 - 联合首席执行官Hicham Chahine表示，此举以快速推进数字基础设施战略，大规模计算能力为公司在游戏娱乐领域探索高性能计算、加密挖矿和AI应用提供了更强基础 [5] - 首席运营官Carl Agren表示，将高效精准地部署这些资产，立即实现稳定产出，并为未来的更高级应用做好准备 [5] - 近期的一系列交易加速了公司数字基础设施能力的建设，彰显了其对实现战略路线图和为股东及合作伙伴创造长期价值的承诺 [5] 公司背景 - NIP Group是一家全球性数字娱乐公司，通过战略性数字基础设施投资推动游戏和电子竞技的演进 [6] - 公司业务生态系统多元化，涵盖电竞战队、场馆与赛事、内容与网红网络、游戏发行、酒店及数字资产运营，触达数亿粉丝 [6] - 公司在欧洲、中东、亚洲和美洲运营，与领先的游戏公司合作以突破互动娱乐的界限 [6]

Vancouver, BC, Nov. 03, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCQB: NIOMF) (“First American”, or the “Company”) announces the change of its stock symbol from URM to NIOB. The common shares of the Company (the “Shares”) will begin trading under the new symbol “NIOB” on the Canadian Securities Exchange at the market open on November 5, 2025. The CUSIP (31858L309) and ISIN (CA31858L3092) for the Shares will remain unchanged. The Company is also pleased to announce its gra ...

MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Peter A. Soukas, M.D., as Chief Medical Officer to advance its mission to deliver best-in-class tools for carotid intervention. “We are thrilled to have Dr. Soukas join InspireMD to help lead our clinical and medical organization with strategy and oversight at this pivotal time for the Comp ...

Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease modifying potentialExhibitor Spotlight to discuss role of CD38 cells across a range of immune-mediated kidney diseasesFelzartamab, an investigational anti-CD38 monoclonal antibody, is a potentially differentiated therapeutic candidate with promise for a broad range of immune-mediated diseases CAM ...

Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option On track to complete the 24-week treatment period and announce topline results in 2026 GAITHERSBURG, Md., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced the completion of patient enrollment in RECLAIM, a Phase 2 clin ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced the Company repurchased 517,500 Ordinary Shares at an average price of $8.58 during October 2025. As of October 31, 2025, Nexxen had 57,086,122 Ordinary Shares outstanding (excluding treasury shares) and approximately $13.9 million remaining under its current share repurchase authoriza ...

MONTREAL, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce the appointment of Mr. Scott Smith as Vice President, Exploration effective November 1, 2025. Mr. Smith joins from Prime Mining Corp. where he most recently served as Executive Vice President, Exploration until its acquisition by Torex Gold Resources Inc. in October 2025. "We are delighted to bolster our exploration team with Scott's appointment. He bring ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company, today announced a significant strengthening of its balance sheet and liquidity position to support its 2026 AI infrastructure development and is also ple ...

COCONUT CREEK, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced that on October 31, 2025, Willis Mitsui & Co. Engine Support Limited (“WMES”), the Company’s long-standing joint venture with Mitsui & Co., Ltd. (“Mitsui”), entered into a new $750.0 million, five-year, revolving credit facility (“Credit Agreement”). Proceeds from the rev ...